tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Novartis AG (NVS)
:NVS
US Market
NVS
Novartis
Overview
Analyst Forecasts
AI Stock Analysis
Popular
Dividends
Earnings
Ownership
Financials
Statistics
New
Technical Analysis
Historical Prices
New
News & Insights
Chart
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports
Advertisement

Novartis (NVS) Stock News & Sentiment

Compare
3,759 Followers
Novartis and Incyte’s Ruxolitinib Study: A Potential Game-Changer for Myelofibrosis Treatment
Premium
Company Announcements
Novartis and Incyte’s Ruxolitinib Study: A Potential Game-Changer for Myelofibrosis Treatment
23h ago
NVS
Pan-Tumor Rollover Study: A New Horizon in Long-term Cancer Treatment
Premium
Company Announcements
Pan-Tumor Rollover Study: A New Horizon in Long-term Cancer Treatment
8d ago
BMY
NVS
Novartis and Olema’s Phase 1b Breast Cancer Study: Market Watch
Premium
Company Announcements
Novartis and Olema’s Phase 1b Breast Cancer Study: Market Watch
8d ago
NVS
Novartis AG: Balancing Promising Drug Developments with Market Challenges – Hold Recommendation
Premium
Ratings
Novartis AG: Balancing Promising Drug Developments with Market Challenges – Hold Recommendation
11d ago
NVS
Novartis Achieves Milestone with Successful Phase III Trials for Sjögren’s Disease Treatment
Premium
Company Announcements
Novartis Achieves Milestone with Successful Phase III Trials for Sjögren’s Disease Treatment
12d ago
6K
NVS
Cautious Optimism: Thibault Boutherin’s Hold Rating on Novartis Amid Balanced Risk-Reward and Growth Prospects
Premium
Ratings
Cautious Optimism: Thibault Boutherin’s Hold Rating on Novartis Amid Balanced Risk-Reward and Growth Prospects
15d ago
NVS
Pan-Tumor Rollover Study: A New Horizon in Cancer Treatment
Premium
Company Announcements
Pan-Tumor Rollover Study: A New Horizon in Cancer Treatment
22d ago
BMY
NVS
More NVS News >

NVS News on the Web

Deutsche Bank Remains a Buy on Novartis AG (NOVN)
TipRanks News
Neutral
INCY Stock Trading Close to Its 52-Week High: Buy, Sell or Hold?
Zacks
Neutral
Eli Lilly (NYSE:LLY) Stock at $703.9 Eyes Recovery as Mounjaro & Zepbound Sales Surge
TradingNEWS.com
Neutral
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Zacks
Neutral
Will EXEL's Share Repurchase Program Boost Value for Investors?
Zacks
Neutral
Eli Lilly's 170% UK price hike for Mounjaro is just the start as pharma firms bow to Trump's pricing pressures
CNBC
Neutral
Massive Headwinds Are on the Horizon for Pharmaceutical Stocks, but Here Are 2 That Could Weather the Storm
The Motley Fool
Neutral
Will Breyanzi's Strong Uptake Help BMY Offset Generic Competition?
Zacks
Neutral

News Score - Last 7 Days

Neutral
NVS
Sector Average
Media Buzz
This Week7 articles
Weekly Average5 articles
News Sentiment
This Week50%
Sector Average55%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is NVS’s Media Buzz Sentiment?
7 articles about NVS were published this week. In an average week, 5 articles are published.
    What is NVS’s weekly average amount of articles?
    In an average week, 5 articles about NVS are published.
      What is NVS’s News Sentiment?
      50% of articles about NVS were positive this week, compared to its sector average of 55%.
        Healthcare Stocks that are Trending in the News
        RGTLFArgent Biopharma
        VKTXViking Therapeutics
        BWAYBrainsway
        PAHCPhibro Animal Health
        MLYSMineralys Therapeutics, Inc.
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing